Evolocumab 用于降低低密度脂蛋白胆固醇和动脉粥样硬化性心血管疾病二级预防的综述

{"title":"Evolocumab 用于降低低密度脂蛋白胆固醇和动脉粥样硬化性心血管疾病二级预防的综述","authors":"Lawrence A. Leiter, Robert A. Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G. B. J. Mancini","doi":"10.31083/j.rcm2505190","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":507771,"journal":{"name":"Reviews in Cardiovascular Medicine","volume":"15 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease\",\"authors\":\"Lawrence A. Leiter, Robert A. Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G. B. J. Mancini\",\"doi\":\"10.31083/j.rcm2505190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":507771,\"journal\":{\"name\":\"Reviews in Cardiovascular Medicine\",\"volume\":\"15 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in Cardiovascular Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31083/j.rcm2505190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31083/j.rcm2505190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}